Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zengtao Yao"'
Autor:
Bingke Bai, Zhe Xu, Yan Hu, Mengmeng Qu, Juan Cheng, Shengdong Luo, Zengtao Yao, Hongyan Gao, Yenv Ma, Rong Gao, Jun Hou, Shaojie Xin, Panyong Mao
Publikováno v:
European Journal of Medical Research, Vol 26, Iss 1, Pp 1-11 (2021)
Abstract Background Hematological comparison of coronavirus disease (COVID-19) and other viral pneumonias can provide insights into COVID-19 treatment. Methods In this retrospective case–control single-center study, we compared the data of 126 pati
Externí odkaz:
https://doaj.org/article/d5bc388bdb89465e83cd807183ebcce6
Autor:
Hao Liao, He Zhang, Jinman Shao, Xiaoyong Li, Wei V. Zheng, Le Li, Guangxin Yu, Lanlan Si, Tao Zhou, Zengtao Yao, Jiuzeng Dai, Dongping Xu, Guanxun Cheng, Jiuxin Qu, Yan Liu, Junhui Chen, Fengmin Lu
Publikováno v:
Journal of Medical Virology. 95
Autor:
Rongjuan Chen, Hao Liao, Jun Zhao, Dongping Xu, Yan Liu, Le Li, Xiaodong Li, Wenhui Liu, Lanlan Si, Yuanhua Li, Wang Jun, Zengtao Yao
Publikováno v:
Antiviral research. 189
Multidrug-resistance hepatitis B virus (MDR HBV), defined as those with mutations resistant to both nucleoside analogs lamivudine/telbivudine/entecavir (LAM/LdT/ETV) and nucleotide analog adefovir (ADV), has potential to cause treatment difficulty. T
Autor:
Mengmeng Qu, Zhe Xu, Jun Hou, Yenv Ma, Juan Cheng, Sheng-dong Luo, Rong Gao, Yan Hu, Hongyan Gao, Shao-jie Xin, Zengtao Yao, Pan-yong Mao, Bing-ke Bai
Publikováno v:
European Journal of Medical Research, Vol 26, Iss 1, Pp 1-11 (2021)
Background Hematological comparison of coronavirus disease (COVID-19) and other viral pneumonias can provide insights into COVID-19 treatment. Methods In this retrospective case–control single-center study, we compared the data of 126 patients with
Autor:
Dongping Xu, Dong Ji, Yan Liu, Lanlan Si, Le Li, Lin Wang, Shaojie Xin, Jiu-zeng Dai, Zhihui Xu, Guofeng Chen, Zengtao Yao, Xiaodong Li
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 54(1)
It remains unclear whether hepatitis B virus (HBV) reverse-transcriptase (RT) rtL229 substitutions influence HBV drug resistance.The study was to investigate the association of HBV rtL229 substitutions with viral resistance to lamivudine (LAM).Entire